369 related articles for article (PubMed ID: 29459003)
1. [Knowledge about Biosimilars in Primary Care: a study by the Spanish Society of Primary Care Physicians (SEMERGEN)].
Micó-Pérez RM; Payares-Herrera C; Palomo-Jiménez PI; Sánchez-Fierro J; Avendaño-Solá C; Llisterri-Caro JL
Semergen; 2018 Sep; 44(6):380-388. PubMed ID: 29459003
[TBL] [Abstract][Full Text] [Related]
2. [Biosimilars: Yes, but with cause knowledge].
Carballo F
Semergen; 2018 Sep; 44(6):369-371. PubMed ID: 30195395
[No Abstract] [Full Text] [Related]
3. Pharmacovigilance and biosimilars: considerations, needs and challenges.
Casadevall N; Edwards IR; Felix T; Graze PR; Litten JB; Strober BE; Warnock DG
Expert Opin Biol Ther; 2013 Jul; 13(7):1039-47. PubMed ID: 23527621
[TBL] [Abstract][Full Text] [Related]
4. Biosimilars - terms of use.
Declerck P; Mellstedt H; Danese S
Curr Med Res Opin; 2015 Dec; 31(12):2325-30. PubMed ID: 26397731
[TBL] [Abstract][Full Text] [Related]
5. A survey of pharmacists' knowledge and views of biosimilars in Quebec and France.
Adé A; Bourdon O; Bussières JF
Ann Pharm Fr; 2017 Jul; 75(4):267-275. PubMed ID: 28237527
[TBL] [Abstract][Full Text] [Related]
6. Biosimilar medical products - licensing, pharmacovigilance and interchangeability.
Grozdanova A; Netkovska KA; Sterjev Z; Naumovska Z; Zarevski R; Dimovski A; Suturkova L
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2016; 37(1):27-36. PubMed ID: 27442414
[TBL] [Abstract][Full Text] [Related]
7. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
van Overbeeke E; De Beleyr B; de Hoon J; Westhovens R; Huys I
BioDrugs; 2017 Oct; 31(5):447-459. PubMed ID: 28929342
[TBL] [Abstract][Full Text] [Related]
8. Biosimilars: Implications for health-system pharmacists.
Lucio SD; Stevenson JG; Hoffman JM
Am J Health Syst Pharm; 2013 Nov; 70(22):2004-17. PubMed ID: 24173009
[TBL] [Abstract][Full Text] [Related]
9. Medical specialists' attitudes to prescribing biosimilars.
Hemmington A; Dalbeth N; Jarrett P; Fraser AG; Broom R; Browett P; Petrie KJ
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):570-577. PubMed ID: 28233367
[TBL] [Abstract][Full Text] [Related]
10. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians.
Cohen H; Beydoun D; Chien D; Lessor T; McCabe D; Muenzberg M; Popovian R; Uy J
Adv Ther; 2017 Jan; 33(12):2160-2172. PubMed ID: 27798772
[TBL] [Abstract][Full Text] [Related]
11. Biosimilars: what clinicians should know.
Weise M; Bielsky MC; De Smet K; Ehmann F; Ekman N; Giezen TJ; Gravanis I; Heim HK; Heinonen E; Ho K; Moreau A; Narayanan G; Kruse NA; Reichmann G; Thorpe R; van Aerts L; Vleminckx C; Wadhwa M; Schneider CK
Blood; 2012 Dec; 120(26):5111-7. PubMed ID: 23093622
[TBL] [Abstract][Full Text] [Related]
12. Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications.
Dowlat HA; Kuhlmann MK; Khatami H; Ampudia-Blasco FJ
Diabetes Obes Metab; 2016 Aug; 18(8):737-46. PubMed ID: 27097592
[TBL] [Abstract][Full Text] [Related]
13. Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey.
Castañeda-Hernández G; Sandoval H; Coindreau J; Rodriguez-Davison LF; Pineda C
Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1035-1044. PubMed ID: 31148288
[TBL] [Abstract][Full Text] [Related]
14. Regulation of biosimilar medicines and current perspectives on interchangeability and policy.
O'Callaghan J; Barry SP; Bermingham M; Morris JM; Griffin BT
Eur J Clin Pharmacol; 2019 Jan; 75(1):1-11. PubMed ID: 30187103
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Physicians' Knowledge and Attitudes Towards Biosimilars in Russia and Issues Associated with Their Prescribing.
Karateev D; Belokoneva N
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30754705
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
Barbier L; Vandenplas Y; Simoens S; Declerck P; Vulto AG; Huys I
J Pharm Policy Pract; 2021 Jun; 14(1):53. PubMed ID: 34158128
[TBL] [Abstract][Full Text] [Related]
17. Nurses' Knowledge and Attitudes towards Biosimilar Medicines as Part of Evidence-Based Nursing Practice-International Pilot Study within the Project Biosimilars Nurses Guide Version 2.0.
Friganović A; Mędrzycka-Dąbrowska W; Krupa S; Oomen B; Decock N; Stievano A
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011946
[TBL] [Abstract][Full Text] [Related]
18. Regulatory challenges with biosimilars: an update from 20 countries.
Kang HN; Thorpe R; Knezevic I; Casas Levano M; Chilufya MB; Chirachanakul P; Chua HM; Dalili D; Foo F; Gao K; Habahbeh S; Hamel H; Kim GH; Perez Rodriguez V; Putri DE; Rodgers J; Savkina M; Semeniuk O; Srivastava S; Tavares Neto J; Wadhwa M; Yamaguchi T
Ann N Y Acad Sci; 2021 May; 1491(1):42-59. PubMed ID: 33222245
[TBL] [Abstract][Full Text] [Related]
19. [The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors].
Jahnz-Rozyk K; Wiesik-Szewczyk E;
Pol Merkur Lekarski; 2014 Jul; 37(217):5-9. PubMed ID: 25154192
[TBL] [Abstract][Full Text] [Related]
20. Biologicals and biosimilars: safety issues in Europe.
Portela MDCC; Sinogas C; Albuquerque de Almeida F; Baptista-Leite R; Castro-Caldas A
Expert Opin Biol Ther; 2017 Jul; 17(7):871-877. PubMed ID: 28540760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]